Please assess the completion status of the following clinical trial:

Trial Title: Stem Cell Transplantation in Ocular Lesions of Behcet's Disease

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Behcet's Disease~* Fulfilling the International Criteria for behcet's Disease (ICBD)~* Ocular lesions with retinal vasculitis~* Resistant to at least 3 months of combination therapy with pulse cyclophosphamide (1g/monthly), azathioprine (3 mg/kg/daily), and prednisolone 0.5 mg/kg/daily~* Visual acuity not less than 4 meters finger count~* Retinal edema confirmed by color photography and OCT~Exclusion Criteria:~* No Vision~* Active posterior uveitis~* Fundus not visible

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): Behcet's Disease with ocular lesions

Based on this trial design, predict the completion outcome and termination type (if applicable).